Clinical Trial Optimization Using R: Chapman & Hall/CRC Biostatistics Series
Editat de Alex Dmitrienko, Erik Pulkstenisen Limba Engleză Hardback – 7 iun 2017
This book presents in depth the Clinical Scenario Evaluation (CSE) framework, and discusses optimization strategies, including the quantitative assessment of tradeoffs. A variety of common development challenges are evaluated as case studies, and used to show how this framework both simplifies and optimizes strategy selection. Specific settings include optimizing adaptive designs, multiplicity and subgroup analysis strategies, and overall development decision-making criteria around Go/No-Go. After this book, the reader will be equipped to extend the CSE framework to their particular development challenges as well.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 311.02 lei 43-57 zile | |
CRC Press – 22 mar 2019 | 311.02 lei 43-57 zile | |
Hardback (1) | 564.57 lei 43-57 zile | |
CRC Press – 7 iun 2017 | 564.57 lei 43-57 zile |
Din seria Chapman & Hall/CRC Biostatistics Series
- 22% Preț: 448.53 lei
- 18% Preț: 570.52 lei
- 26% Preț: 680.32 lei
- 26% Preț: 624.69 lei
- 18% Preț: 547.45 lei
- 25% Preț: 773.58 lei
- 26% Preț: 850.48 lei
- 13% Preț: 337.80 lei
- 26% Preț: 625.08 lei
- 18% Preț: 868.11 lei
- 25% Preț: 497.35 lei
- 26% Preț: 552.42 lei
- 26% Preț: 870.09 lei
- 25% Preț: 487.07 lei
- 26% Preț: 623.46 lei
- 26% Preț: 523.78 lei
- 26% Preț: 768.72 lei
- 26% Preț: 495.73 lei
- 22% Preț: 357.66 lei
- 26% Preț: 484.23 lei
- 26% Preț: 625.08 lei
- 26% Preț: 763.06 lei
- 23% Preț: 426.66 lei
- 8% Preț: 564.25 lei
- 26% Preț: 598.23 lei
- 25% Preț: 771.94 lei
- 25% Preț: 498.96 lei
- 25% Preț: 1214.28 lei
- 26% Preț: 623.05 lei
- 26% Preț: 820.87 lei
- 25% Preț: 554.37 lei
- 26% Preț: 622.23 lei
- 26% Preț: 878.64 lei
- 26% Preț: 882.44 lei
- 25% Preț: 557.13 lei
- 22% Preț: 361.01 lei
- 26% Preț: 524.19 lei
- 26% Preț: 594.17 lei
- 25% Preț: 528.26 lei
- 26% Preț: 521.35 lei
- 26% Preț: 495.33 lei
- 26% Preț: 678.84 lei
- 25% Preț: 774.77 lei
- 22% Preț: 478.75 lei
- 26% Preț: 623.05 lei
- 26% Preț: 625.63 lei
- 25% Preț: 685.51 lei
Preț: 564.57 lei
Preț vechi: 749.90 lei
-25% Nou
Puncte Express: 847
Preț estimativ în valută:
108.06€ • 112.62$ • 89.95£
108.06€ • 112.62$ • 89.95£
Carte tipărită la comandă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781498735070
ISBN-10: 149873507X
Pagini: 338
Ilustrații: 100 Illustrations, black and white
Dimensiuni: 156 x 234 x 21 mm
Greutate: 1.3 kg
Ediția:1
Editura: CRC Press
Colecția Chapman and Hall/CRC
Seria Chapman & Hall/CRC Biostatistics Series
ISBN-10: 149873507X
Pagini: 338
Ilustrații: 100 Illustrations, black and white
Dimensiuni: 156 x 234 x 21 mm
Greutate: 1.3 kg
Ediția:1
Editura: CRC Press
Colecția Chapman and Hall/CRC
Seria Chapman & Hall/CRC Biostatistics Series
Cuprins
Introduction to Clinical Scenario Evaluation. Clinical Scenario Evaluation and Clinical Trial Optimization. General Clinical Trials Settings. Clinical Trials with Multiple Objectives. Clinical Trials with Adaptive Designs. Subgroup Analysis in Clinical Trials. Dose-Finding Clinical Trials. Bayesian Approaches in Clinical Trials
Notă biografică
Alex Dmitrienko is President at Mediana Inc. He has been actively involved in biostatistical research with emphasis on multiplicity issues in clinical trials, subgroup analysis, innovative trial designs and clinical trial optimization. He has published over 90 papers and authored/edited three books. Dr. Dmitrienko is a Fellow of the American Statistical Association.
Erik Pulkstenis is Vice President, Clinical Biostatistics and Data Management at MedImmune, and has worked in the medical device and biopharmaceutical industry for over 20 years. In addition, he served as a faculty member for the Institute for Professional Education teaching on categorical data analysis. His research interests include evidence-based decision making, precision medicine, and applications of statistical methods in oncology.
Erik Pulkstenis is Vice President, Clinical Biostatistics and Data Management at MedImmune, and has worked in the medical device and biopharmaceutical industry for over 20 years. In addition, he served as a faculty member for the Institute for Professional Education teaching on categorical data analysis. His research interests include evidence-based decision making, precision medicine, and applications of statistical methods in oncology.
Recenzii
"The book Clinical Trial Optimization Using R by A. Dmitrienko and E. Pulkstenis gives a comprehensible introduction to the subject of Clinical Scenario Evaluation (CSE) and subsequent optimization . . . The authors present an approach that is easy to understand and to implement in R. The book is well structured, and the underlying principles are described in detail and illustrated by several case studies."
~ Kiana Kreitz, Institute of Biostatistics and Clinical Research, Germany
~ Kiana Kreitz, Institute of Biostatistics and Clinical Research, Germany
Descriere
The main goal of this book is to define a unified framework for clinical trial optimization based on a comprehensive quantitative evaluation of relevant clinical scenarios (using the clinical scenario evaluation approach) and introduce best practices for simulationbased optimization. The book will be aimed at a broad audience and will emphasize a hands-on approach with a detailed discussion of practical issues arising in clinical trial optimization and R software implementation (relevant statistical methodology will be moved to the appendix).